Tong Ren Tang Technologies Co Ltd vs Sinovac Biotech Ltd.
A side-by-side look at two Chinese stocks — live quote, valuation, growth, listing venue, dual-listing and delisting status, and the WealthyTec Rank. A factual comparison for orientation, not investment advice.
| Metric | Tong Ren Tang Technologies Co Ltd 1666.HK · Hong Kong 3.27 HKD | Sinovac Biotech Ltd. SVA · US (ADR) 6.47 USD |
|---|---|---|
| Day change | -0.30% | 0.00% |
| Market cap | $534.4M | $368.9M |
| P/E (TTM) | — | — |
| 2y EPS CAGR | — | — |
| WealthyTec Rank | 6.1 | 0.6 |
| Rank within sector | #12 of 31 | #31 of 31 |
| Listing venue | HKEX | NYSE / NASDAQ (ADR) |
| Other listings | n/a | n/a |
| Delisting filings | None on record | None on record |
| Sector | Health Care | Health Care |
| Industry | Biotech and Pharma | Biotech and Pharma |
Of the two, Tong Ren Tang Technologies Co Ltd currently carries the higher WealthyTec Rank (6.1 vs 0.6). The Rank reflects past revenue, earnings and EPS trends only — not valuation, momentum, or the policy and delisting risks every China investor should weigh, and it is not a recommendation to buy, sell or hold either security. See our rank methodology.